The European Union is experiencing considerable demographic ageing. This is putting at risk the sustainability of public finances, including health care funding. The increase in life expectancy is accompanied by a change in the main causes of morbidity and mortality, with over 70% attributable to chronic diseases.
The prevention and understanding of chronic diseases and ageing are at the heart of the European Union's concerns and now constitute a major public health and research axis for the Montpellier-Nîmes site.
The Partnership Foundation called "Foundation for Chronic Diseases and Active Ageing - Languedoc-Roussillon (FMAC VIA-LR)" meets this strategic commitment. It was founded by the University of Montpellier, the University Hospital Centres of Montpellier and Nîmes and the Occitanie Region and was created by order of the Rector of the Montpellier Academy, Chancellor of the Universities, on 9 September 2015 (MENESR: Ministry of National Education, Higher Education and Research).
The European Union has labelled 74 Reference Sites including MACVIA-France (Against Chronic Diseases for Active and Healthy Ageing in France). This site includes centres in the Occitanie region with Montpellier, Nîmes and Toulouse, the metropolis of Nice and an INSERM research centre in Paris.
The Reference Site responds to all the axes proposed by the Commission (polymedication in the elderly, prevention and management of falls, frailty, chronic diseases, friendly cities and Silver Economy). It is based on the recognised excellence of the participants. The MACVIA-France Reference Site is supported by the FMAC VIA-LR Partnership Foundation.